Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Characterization of molecular mechanisms underlying the axonal Charcot-Marie-Tooth neuropathy caused by MORC2 mutations

P. Sancho, L. Bartesaghi, O. Miossec, F. García-García, L. Ramírez-Jiménez, A. Siddell, E. Åkesson, E. Hedlund, P. Laššuthová, SI. Pascual-Pascual, T. Sevilla, M. Kennerson, V. Lupo, R. Chrast, C. Espinós,

. 2019 ; 28 (10) : 1629-1644. [pub] 20190515

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20006660

Grantová podpora
NV16-30206A MZ0 CEP - Centrální evidence projektů

Mutations in MORC2 lead to an axonal form of Charcot-Marie-Tooth (CMT) neuropathy type 2Z. To date, 31 families have been described with mutations in MORC2, indicating that this gene is frequently involved in axonal CMT cases. While the genetic data clearly establish the causative role of MORC2 in CMT2Z, the impact of its mutations on neuronal biology and their phenotypic consequences in patients remains to be clarified. We show that the full-length form of MORC2 is highly expressed in both embryonic and adult human neural tissues and that Morc2 expression is dynamically regulated in both the developing and the maturing murine nervous system. To determine the effect of the most common MORC2 mutations, p.S87L and p.R252W, we used several in vitro cell culture paradigms. Both mutations induced transcriptional changes in patient-derived fibroblasts and when expressed in rodent sensory neurons. These changes were more pronounced and accompanied by abnormal axonal morphology, in neurons expressing the MORC2 p.S87L mutation, which is associated with a more severe clinical phenotype. These data provide insight into the neuronal specificity of the mutated MORC2-mediated phenotype and highlight the importance of neuronal cell models to study the pathophysiology of CMT2Z.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006660
003      
CZ-PrNML
005      
20200522110535.0
007      
ta
008      
200511s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/hmg/ddz006 $2 doi
035    __
$a (PubMed)30624633
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Sancho, Paula $u Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
245    10
$a Characterization of molecular mechanisms underlying the axonal Charcot-Marie-Tooth neuropathy caused by MORC2 mutations / $c P. Sancho, L. Bartesaghi, O. Miossec, F. García-García, L. Ramírez-Jiménez, A. Siddell, E. Åkesson, E. Hedlund, P. Laššuthová, SI. Pascual-Pascual, T. Sevilla, M. Kennerson, V. Lupo, R. Chrast, C. Espinós,
520    9_
$a Mutations in MORC2 lead to an axonal form of Charcot-Marie-Tooth (CMT) neuropathy type 2Z. To date, 31 families have been described with mutations in MORC2, indicating that this gene is frequently involved in axonal CMT cases. While the genetic data clearly establish the causative role of MORC2 in CMT2Z, the impact of its mutations on neuronal biology and their phenotypic consequences in patients remains to be clarified. We show that the full-length form of MORC2 is highly expressed in both embryonic and adult human neural tissues and that Morc2 expression is dynamically regulated in both the developing and the maturing murine nervous system. To determine the effect of the most common MORC2 mutations, p.S87L and p.R252W, we used several in vitro cell culture paradigms. Both mutations induced transcriptional changes in patient-derived fibroblasts and when expressed in rodent sensory neurons. These changes were more pronounced and accompanied by abnormal axonal morphology, in neurons expressing the MORC2 p.S87L mutation, which is associated with a more severe clinical phenotype. These data provide insight into the neuronal specificity of the mutated MORC2-mediated phenotype and highlight the importance of neuronal cell models to study the pathophysiology of CMT2Z.
650    _2
$a zvířata $7 D000818
650    _2
$a axony $x metabolismus $x patologie $7 D001369
650    _2
$a Charcotova-Marieova-Toothova nemoc $x genetika $x patologie $7 D002607
650    _2
$a embryonální kmenové buňky $x metabolismus $7 D053595
650    _2
$a fibroblasty $x metabolismus $x patologie $7 D005347
650    _2
$a regulace genové exprese $x genetika $7 D005786
650    _2
$a lidé $7 D006801
650    _2
$a mutace $x genetika $7 D009154
650    _2
$a nervové kmenové buňky $7 D058953
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a nervové receptory $x metabolismus $x patologie $7 D011984
650    _2
$a transkripční faktory $x genetika $7 D014157
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bartesaghi, Luca $u Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden. Department of Clinical Neuroscience, Karolinska Institutet, 17165 Stockholm, Sweden.
700    1_
$a Miossec, Olivia $u Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden. Department of Clinical Neuroscience, Karolinska Institutet, 17165 Stockholm, Sweden.
700    1_
$a García-García, Francisco $u Unit of Bioinformatics and Biostatistics, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
700    1_
$a Ramírez-Jiménez, Laura $u Department of Genomics and Translational Genetics, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
700    1_
$a Siddell, Anna $u Northcott Neuroscience Laboratory, ANZAC Research Institute, Concord NSW, Australia. Sydney Medical School, University of Sydney, Sydney NSW, Australia.
700    1_
$a Åkesson, Elisabet $u Division of Neurodegeneration, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden. The R&D Unit, Stiftelsen Stockholms Sjukhemm, 14152, Sweden.
700    1_
$a Hedlund, Eva $u Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Laššuthová, Petra $u Department of Pediatric Neurology, DNA Laboratory, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.
700    1_
$a Pascual-Pascual, Samuel I $u Department of Pediatric Neurology, Hospital Universitario La Paz, Madrid, Spain.
700    1_
$a Sevilla, Teresa $u Department of Neurology, Hospital Universitari i Politècnic La Fe, and CIBER of Rare Diseases (CIBERER), Valencia, Spain. Department of Medicine, University of Valencia, Valencia, Spain.
700    1_
$a Kennerson, Marina $u Northcott Neuroscience Laboratory, ANZAC Research Institute, Concord NSW, Australia. Sydney Medical School, University of Sydney, Sydney NSW, Australia. Molecular Medicine Laboratory, Concord Hospital, Concord NSW, Australia.
700    1_
$a Lupo, Vincenzo $u Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain. Department of Genomics and Translational Genetics, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain. INCLIVA & IIS-La Fe Rare Diseases Joint Units, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
700    1_
$a Chrast, Roman $u Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden. Department of Clinical Neuroscience, Karolinska Institutet, 17165 Stockholm, Sweden.
700    1_
$a Espinós, Carmen $u Unit of Genetics and Genomics of Neuromuscular and Neurodegenerative Disorders, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain. Department of Genomics and Translational Genetics, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain. INCLIVA & IIS-La Fe Rare Diseases Joint Units, Centro de Investigación Príncipe Felipe (CIPF), Valencia, Spain.
773    0_
$w MED00002077 $t Human molecular genetics $x 1460-2083 $g Roč. 28, č. 10 (2019), s. 1629-1644
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30624633 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200522110533 $b ABA008
999    __
$a ok $b bmc $g 1525518 $s 1096716
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 28 $c 10 $d 1629-1644 $e 20190515 $i 1460-2083 $m Human molecular genetics $n Hum Mol Genet $x MED00002077
GRA    __
$a NV16-30206A $p MZ0
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...